Immunization and MS: A summary of published evidence and recommendations

Olivier T. Rutschmann; Douglas C. McCrory; David B. Matchar; Dennis Bourdette; Lois Copperman; Patricia Coyle; Frank DeStafano; Thomas Marrie; Deborah Miller; Cindy Phair; John Richert; Douglas S. Goodin; Carmel Armon; Elliot Frohman; Robert S. Goldman; David Hammond; Chung Y. Hsu; Andres M. Kanner; David S. Lefkowitz; Isaac E. Silverman; Michael A. Sloan; Yuen T. So

doi:10.1212/WNL.59.12.1837

Immunization and MS: A summary of published evidence and recommendations

Olivier T. Rutschmann, Douglas C. McCrory, David B. Matchar, Dennis Bourdette, Lois Copperman, Patricia Coyle, Frank DeStafano, Thomas Marrie, Deborah Miller, Cindy Phair, John Richert, Douglas S. Goodin, Carmel Armon, Elliot Frohman, Robert S. Goldman, David Hammond, Chung Y. Hsu, Andres M. Kanner, David S. Lefkowitz, Isaac E. SilvermanMichael A. Sloan, Yuen T. So

Research output: Contribution to journal › Article › peer-review

100 Scopus citations

Abstract

Objective: To review the risk of MS exacerbations after infectious episodes potentially preventable by vaccination, and the risks and benefits of immunizing patients with MS. Methods: The authors searched MEDLINE (1966 to January 2001; U.S. National Library of Medicine, Bethesda, MD), HealthSTAR, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) database (Cinahl Information Systems, Glendale, CA) for English-language articles. Each study was summarized and rated for quality of evidence. Then feasible data were pooled and analyzed in metaanalysis. Results: The risk of contracting common infectious diseases in patients with MS is not well established. There is strong evidence for an increased risk of MS exacerbations during weeks around an infectious episode. There is strong evidence against an increased risk of MS exacerbation after influenza immunization. There is no evidence that hepatitis B, varicella, tetanus, or Bacille Calmette-Guerin vaccines increase the risk of MS exacerbations. Insufficient evidence was found for other vaccines. Conclusions: Evidence supports 1) strategies to minimize the risk of acquiring infectious diseases that may trigger exacerbations of MS; and 2) the safety of using influenza, hepatitis B, varicella, tetanus, and Bacille Calmette-Guerin (BCG) vaccines in patients with MS.

Original language	English (US)
Pages (from-to)	1837-1843
Number of pages	7
Journal	Neurology
Volume	59
Issue number	12
DOIs	https://doi.org/10.1212/WNL.59.12.1837
State	Published - Dec 24 2002

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.59.12.1837

Cite this

Rutschmann, O. T., McCrory, D. C., Matchar, D. B., Bourdette, D., Copperman, L., Coyle, P., DeStafano, F., Marrie, T., Miller, D., Phair, C., Richert, J., Goodin, D. S., Armon, C., Frohman, E., Goldman, R. S., Hammond, D., Hsu, C. Y., Kanner, A. M., Lefkowitz, D. S., ... So, Y. T. (2002). Immunization and MS: A summary of published evidence and recommendations. Neurology, 59(12), 1837-1843. https://doi.org/10.1212/WNL.59.12.1837

Rutschmann, OT, McCrory, DC, Matchar, DB, Bourdette, D, Copperman, L, Coyle, P, DeStafano, F, Marrie, T, Miller, D, Phair, C, Richert, J, Goodin, DS, Armon, C, Frohman, E, Goldman, RS, Hammond, D, Hsu, CY, Kanner, AM, Lefkowitz, DS, Silverman, IE, Sloan, MA & So, YT 2002, 'Immunization and MS: A summary of published evidence and recommendations', Neurology, vol. 59, no. 12, pp. 1837-1843. https://doi.org/10.1212/WNL.59.12.1837

@article{9b597ccfd20b4b4bbb056fea5d78f41b,

title = "Immunization and MS: A summary of published evidence and recommendations",

abstract = "Objective: To review the risk of MS exacerbations after infectious episodes potentially preventable by vaccination, and the risks and benefits of immunizing patients with MS. Methods: The authors searched MEDLINE (1966 to January 2001; U.S. National Library of Medicine, Bethesda, MD), HealthSTAR, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) database (Cinahl Information Systems, Glendale, CA) for English-language articles. Each study was summarized and rated for quality of evidence. Then feasible data were pooled and analyzed in metaanalysis. Results: The risk of contracting common infectious diseases in patients with MS is not well established. There is strong evidence for an increased risk of MS exacerbations during weeks around an infectious episode. There is strong evidence against an increased risk of MS exacerbation after influenza immunization. There is no evidence that hepatitis B, varicella, tetanus, or Bacille Calmette-Guerin vaccines increase the risk of MS exacerbations. Insufficient evidence was found for other vaccines. Conclusions: Evidence supports 1) strategies to minimize the risk of acquiring infectious diseases that may trigger exacerbations of MS; and 2) the safety of using influenza, hepatitis B, varicella, tetanus, and Bacille Calmette-Guerin (BCG) vaccines in patients with MS.",

author = "Rutschmann, {Olivier T.} and McCrory, {Douglas C.} and Matchar, {David B.} and Dennis Bourdette and Lois Copperman and Patricia Coyle and Frank DeStafano and Thomas Marrie and Deborah Miller and Cindy Phair and John Richert and Goodin, {Douglas S.} and Carmel Armon and Elliot Frohman and Goldman, {Robert S.} and David Hammond and Hsu, {Chung Y.} and Kanner, {Andres M.} and Lefkowitz, {David S.} and Silverman, {Isaac E.} and Sloan, {Michael A.} and So, {Yuen T.}",

year = "2002",

month = dec,

day = "24",

doi = "10.1212/WNL.59.12.1837",

language = "English (US)",

volume = "59",

pages = "1837--1843",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

TY - JOUR

T1 - Immunization and MS

T2 - A summary of published evidence and recommendations

AU - Rutschmann, Olivier T.

AU - McCrory, Douglas C.

AU - Matchar, David B.

AU - Bourdette, Dennis

AU - Copperman, Lois

AU - Coyle, Patricia

AU - DeStafano, Frank

AU - Marrie, Thomas

AU - Miller, Deborah

AU - Phair, Cindy

AU - Richert, John

AU - Goodin, Douglas S.

AU - Armon, Carmel

AU - Frohman, Elliot

AU - Goldman, Robert S.

AU - Hammond, David

AU - Hsu, Chung Y.

AU - Kanner, Andres M.

AU - Lefkowitz, David S.

AU - Silverman, Isaac E.

AU - Sloan, Michael A.

AU - So, Yuen T.

PY - 2002/12/24

Y1 - 2002/12/24

N2 - Objective: To review the risk of MS exacerbations after infectious episodes potentially preventable by vaccination, and the risks and benefits of immunizing patients with MS. Methods: The authors searched MEDLINE (1966 to January 2001; U.S. National Library of Medicine, Bethesda, MD), HealthSTAR, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) database (Cinahl Information Systems, Glendale, CA) for English-language articles. Each study was summarized and rated for quality of evidence. Then feasible data were pooled and analyzed in metaanalysis. Results: The risk of contracting common infectious diseases in patients with MS is not well established. There is strong evidence for an increased risk of MS exacerbations during weeks around an infectious episode. There is strong evidence against an increased risk of MS exacerbation after influenza immunization. There is no evidence that hepatitis B, varicella, tetanus, or Bacille Calmette-Guerin vaccines increase the risk of MS exacerbations. Insufficient evidence was found for other vaccines. Conclusions: Evidence supports 1) strategies to minimize the risk of acquiring infectious diseases that may trigger exacerbations of MS; and 2) the safety of using influenza, hepatitis B, varicella, tetanus, and Bacille Calmette-Guerin (BCG) vaccines in patients with MS.

AB - Objective: To review the risk of MS exacerbations after infectious episodes potentially preventable by vaccination, and the risks and benefits of immunizing patients with MS. Methods: The authors searched MEDLINE (1966 to January 2001; U.S. National Library of Medicine, Bethesda, MD), HealthSTAR, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) database (Cinahl Information Systems, Glendale, CA) for English-language articles. Each study was summarized and rated for quality of evidence. Then feasible data were pooled and analyzed in metaanalysis. Results: The risk of contracting common infectious diseases in patients with MS is not well established. There is strong evidence for an increased risk of MS exacerbations during weeks around an infectious episode. There is strong evidence against an increased risk of MS exacerbation after influenza immunization. There is no evidence that hepatitis B, varicella, tetanus, or Bacille Calmette-Guerin vaccines increase the risk of MS exacerbations. Insufficient evidence was found for other vaccines. Conclusions: Evidence supports 1) strategies to minimize the risk of acquiring infectious diseases that may trigger exacerbations of MS; and 2) the safety of using influenza, hepatitis B, varicella, tetanus, and Bacille Calmette-Guerin (BCG) vaccines in patients with MS.

UR - http://www.scopus.com/inward/record.url?scp=0037168795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037168795&partnerID=8YFLogxK

U2 - 10.1212/WNL.59.12.1837

DO - 10.1212/WNL.59.12.1837

M3 - Article

C2 - 12499473

AN - SCOPUS:0037168795

SN - 0028-3878

VL - 59

SP - 1837

EP - 1843

JO - Neurology

JF - Neurology

IS - 12

ER -

Immunization and MS: A summary of published evidence and recommendations

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this